Published in JAMA Surg on October 01, 2015
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med (2017) 3.53
Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ (2016) 2.04
Mass Treatment With Bariatric Surgery for Type 2 Diabetes Mellitus. JAMA Surg (2016) 1.06
Obstructive sleep apnea as a risk factor for type 2 diabetes mellitus. Nat Sci Sleep (2015) 0.85
Metabolic Surgery for Type 2 Diabetes: Changing the Landscape of Diabetes Care. Diabetes Care (2016) 0.83
Bariatric Surgery and Long-term Durability of Weight Loss. JAMA Surg (2016) 0.83
Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease? Clin J Am Soc Nephrol (2015) 0.83
Non-alcoholic fatty liver disease and diabetes. Metabolism (2016) 0.82
Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth. Diabetes Care (2016) 0.81
Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial. Diabetes Care (2016) 0.80
Dose response of exercise training following roux-en-Y gastric bypass surgery: A randomized trial. Obesity (Silver Spring) (2015) 0.79
The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. Oncotarget (2016) 0.79
Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore) (2016) 0.78
Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes. PLoS One (2016) 0.76
Risk of post-gastric bypass surgery hypoglycemia in nondiabetic individuals: A single center experience. Obesity (Silver Spring) (2016) 0.76
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications. Diabetes Care (2016) 0.76
The safety of laparoscopic sleeve gastrectomy among diabetic patients. Surg Endosc (2016) 0.76
Bariatric Surgery for Type 2 Diabetes: Getting Closer to the Long-term Goal. JAMA (2016) 0.75
Binge-eating disorder and the outcome of bariatric surgery in a prospective, observational study: Two-year results. Obesity (Silver Spring) (2016) 0.75
Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus. JAMA Surg (2015) 0.75
Surgical Treatment of Metabolic Syndrome. Visc Med (2016) 0.75
Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect. Diabetes Care (2016) 0.75
Mass Treatment With Bariatric Surgery for Type 2 Diabetes Mellitus-Reply. JAMA Surg (2016) 0.75
Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity. Minerva Endocrinol (2015) 0.75
Outcomes associated with preoperative weight loss after laparoscopic Roux-en-Y gastric bypass. Surg Endosc (2016) 0.75
Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol (2016) 0.75
Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus. Oncotarget (2016) 0.75
Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis. Obes Surg (2017) 0.75
Hypocalcemia After Bariatric Surgery: Prevalence and Associated Risk Factors. Obes Surg (2017) 0.75
Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy. Curr Diab Rep (2017) 0.75
The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord (2017) 0.75
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA (2008) 13.69
Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (2012) 13.59
The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care (2002) 11.65
Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med (2012) 11.25
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med (2014) 10.66
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97
Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg (1995) 9.02
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med (2010) 8.77
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg (2003) 6.50
Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med (2006) 5.54
Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ (2013) 5.08
Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) (2011) 3.62
How do we define cure of diabetes? Diabetes Care (2009) 3.59
Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA (2013) 3.57
Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med (2010) 2.90
Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA Surg (2014) 2.57
Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA (2013) 2.49
Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg (2014) 1.41
Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg (2014) 1.40
Long-term risks and benefits of bariatric surgery: a research challenge. JAMA (2014) 0.97
Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA (2013) 3.57
Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study. Semin Liver Dis (2014) 1.56
Urinary Incontinence Before and After Bariatric Surgery. JAMA Intern Med (2015) 1.47
Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg (2014) 1.40
Postoperative Behavioral Variables and Weight Change 3 Years After Bariatric Surgery. JAMA Surg (2016) 0.83
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. Gastroenterology (2015) 0.81
Retention and attrition in bariatric surgery research: an integrative review of the literature. Surg Obes Relat Dis (2015) 0.75
Mass Treatment With Bariatric Surgery for Type 2 Diabetes Mellitus-Reply. JAMA Surg (2016) 0.75
No Rush to Judgment for Bariatric Surgery. JAMA Surg (2015) 0.75
Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg (2017) 0.75
Alcohol and other substance use after bariatric surgery: prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis (2017) 0.75
Use of prescribed opioids before and after bariatric surgery: prospective evidence from a U.S. multicenter cohort study. Surg Obes Relat Dis (2017) 0.75